Therapy of Graves' ophthalmopathy: a novel application of somatostatin analogues.

Suppr

超能文献

作者信息

Díez J J

出版信息

Expert Opin Pharmacother. 2001 Sep;2(9):1361-5. doi: 10.1517/14656566.2.9.1361.

DOI:10.1517/14656566.2.9.1361

PMID:11585016

Abstract

摘要

相似文献

Therapy of Graves' ophthalmopathy: a novel application of somatostatin analogues.

Expert Opin Pharmacother. 2001 Sep;2(9):1361-5. doi: 10.1517/14656566.2.9.1361.

The role of somatostatin analogs in the management of Graves' ophthalmopathy.

J Endocrinol Invest. 2003;26(8 Suppl):109-13.

Somatostatin therapy and Graves' ophthalmopathy.

Thyroid. 1997 Jun;7(3):489. doi: 10.1089/thy.1997.7.489.

[Somatostatin analogue treatment in Graves' ophthalmopathy: a case report].

Arch Soc Esp Oftalmol. 2007 Jan;82(1):51-4. doi: 10.4321/s0365-66912007000100010.

Somatostatin analogs for Graves' ophthalmopathy: do they bounce off like a rubber bullet?

J Clin Endocrinol Metab. 2004 Dec;89(12):5908-9. doi: 10.1210/jc.2004-1981.

Somatostatin analogs: a new tool for the management of Graves' ophthalmopathy.

J Endocrinol Invest. 2004 Mar;27(3):281-7. doi: 10.1007/BF03345278.

Graves' ophthalmopathy: state of the art and perspectives.

J Endocrinol Invest. 2004 Mar;27(3):295-301. doi: 10.1007/BF03345280.

Somatostatin analogues in the treatment of thyroid eye disease.

Thyroid. 1998 May;8(5):443-5. doi: 10.1089/thy.1998.8.443.

Lanreotide treatment in a patient with interferon-associated Graves' ophthalmopathy.

Graefes Arch Clin Exp Ophthalmol. 2005 Mar;243(3):269-72. doi: 10.1007/s00417-004-1012-x. Epub 2004 Sep 28.

[Somatostatin analogs].

Pol Arch Med Wewn. 2006 Oct;116(4):988-97.

引用本文的文献

Slow-release lanreotide in Graves' ophthalmopathy: A double-blind randomized, placebo-controlled clinical trial.

J Endocrinol Invest. 2006 May;29(5):413-22. doi: 10.1007/BF03344124.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Therapy of Graves' ophthalmopathy: a novel application of somatostatin analogues.

Expert Opin Pharmacother. 2001 Sep;2(9):1361-5. doi: 10.1517/14656566.2.9.1361.

The role of somatostatin analogs in the management of Graves' ophthalmopathy.

J Endocrinol Invest. 2003;26(8 Suppl):109-13.

Somatostatin therapy and Graves' ophthalmopathy.

Thyroid. 1997 Jun;7(3):489. doi: 10.1089/thy.1997.7.489.

[Somatostatin analogue treatment in Graves' ophthalmopathy: a case report].

Arch Soc Esp Oftalmol. 2007 Jan;82(1):51-4. doi: 10.4321/s0365-66912007000100010.

Somatostatin analogs for Graves' ophthalmopathy: do they bounce off like a rubber bullet?

J Clin Endocrinol Metab. 2004 Dec;89(12):5908-9. doi: 10.1210/jc.2004-1981.

Somatostatin analogs: a new tool for the management of Graves' ophthalmopathy.

J Endocrinol Invest. 2004 Mar;27(3):281-7. doi: 10.1007/BF03345278.

Graves' ophthalmopathy: state of the art and perspectives.

J Endocrinol Invest. 2004 Mar;27(3):295-301. doi: 10.1007/BF03345280.

Somatostatin analogues in the treatment of thyroid eye disease.

Thyroid. 1998 May;8(5):443-5. doi: 10.1089/thy.1998.8.443.

Lanreotide treatment in a patient with interferon-associated Graves' ophthalmopathy.

Graefes Arch Clin Exp Ophthalmol. 2005 Mar;243(3):269-72. doi: 10.1007/s00417-004-1012-x. Epub 2004 Sep 28.

[Somatostatin analogs].

Pol Arch Med Wewn. 2006 Oct;116(4):988-97.

引用本文的文献

Slow-release lanreotide in Graves' ophthalmopathy: A double-blind randomized, placebo-controlled clinical trial.

J Endocrinol Invest. 2006 May;29(5):413-22. doi: 10.1007/BF03344124.